BACK TO BACK LATEST NEWS, Official Website about ,all over the world latest news, Entertainment,Sports,Health,Fashion Hollywood,Bollywood ,Business,Latest Stories,Political news,Stock market news,and Hot news and more other topics
GV, Alphabet Inc's venture capital arm, led a $58.5 million investment to launch Verve Therapeutics, a new biotech focused on developing therapies that edit the human genome to treat heart diseases.
0 comments:
Post a Comment